🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To evaluate the immune response and the safety of a primary series schedule...
Status
Completed
Location
Multiple Locations
Start Date
2013-05-01
Trial ID
NCT01839188
Treatments Being Tested
The main goal of this study is to compare the Haemophilus influenzae type b...
Status
Completed
Location
Alaska Native Medical Center
Start Date
2022-01-27
Trial ID
NCT04978818
The purpose of this study was to assess the safety and immunogenicity of GS...
Status
Completed
Location
GSK Investigational Site
Start Date
2021-05-26
Trial ID
NCT04535037
Treatments Being Tested
The purpose of this clinical study is to evaluate the safety and immunogeni...
Status
Completed
Location
Hvidovre Hospital ( Site 0003)
Start Date
2019-08-28
Trial ID
NCT04016714
Treatments Being Tested
The purpose of this study is to demonstrate the durability of protection ag...
Status
Completed
Location
Tampereen yliopisto Kokkolan rokotetutkimusklinikka ( Site 0009)
Start Date
2020-09-02
Trial ID
NCT04490499
Treatments Being Tested
The overall objective of the project is to identify the determinants of ant...
Status
Completed
Location
CHU Saint-Pierre
Start Date
2023-09-12
Trial ID
NCT05856396
Treatments Being Tested
This study is a Phase 3, randomized, modified double-blind study which aims...
Status
Active Not Recruiting
Location
Sun City Clinical Research- Site Number : 8400247
Start Date
2024-12-18
Trial ID
NCT06736041
Treatments Being Tested
This study is a Phase 3, randomized, modified double-blind study which aims...
Status
Active Not Recruiting
Location
Kaiser Permanente - Los Angeles Medical Center- Site Number : 8400025
Start Date
2025-02-27
Trial ID
NCT06824181
The primary objectives of this study are to evaluate the immunogenicity and...
Status
Completed
Location
Multiple Locations
Start Date
2012-03-30
Trial ID
NCT01553279
Treatments Being Tested
This study is a Phase 3, randomized, modified double-blind study which aims...
Status
Active Not Recruiting
Location
Alabama Clinical Therapeutics - Birmingham - St. Vincent's Drive- Site Number : 8400013
Start Date
2025-02-18
Trial ID
NCT06824194